secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001193125-24-230283
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio raises $12.4M in private placement; amends Series A warrants
-------------------------------------------------------------------

- Gross proceeds of ~$12.4M from sale of units at $0.3950 per unit; closing expected Oct 4, 2024.
- Units consist of common stock or pre-funded warrants plus Series C warrants (exercise price $0.27, 3-year term).
- Series A warrants amended: exercise price reduced from $1.25 to $0.45, term extended by one year from closing.
- Company to file resale registration statement within 30 days of closing.
- Funds expected to support operating plan into 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312524230283/0001193125-24-230283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312524230283/d895981d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-230283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer